Is a complete IRMD research report available?

No complete published report is available for IRADIMED CORPORATION (IRMD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

IRADIMED CORPORATION (IRMD)

NASDAQ: IRMD · USD

$83.8

-0.12 (-0.1%)· Recorded snapshot

Market cap	1.1B
Revenue (ttm)	86.3M
Net income (ttm)	23.1M
EPS (ttm)	$1.79
Shares out	12.8M
P/E (trailing)	46.8x
P/E (forward)	38.8x
Dividend	$0.80 (0.96%)
Volume	144,278
Beta	0.91

Market data

Price

Recent price action with selectable time range.

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Metric	Value
Amount currency	USD
CIK code	0001325618
Company name	IRADIMED CORPORATION
Country	United States
Country code	US
CUSIP number	46266A109
Earnings date	2026-10-30
Earnings time	bmo
Employees	166
Employees change	6
Employees growth	3.75%
Enterprise value	$1B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1992
In index	RUSSELL2000
Industry	Medical Devices
IPO date	2014-07-16
Is primary listing	Yes
Is SPAC	No
ISIN number	US46266A1097
Last 10-K release date	2026-03-06
Last earnings date	2026-07-31
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$1.1B
Market cap category	Small-Cap
Next earnings date	2026-10-30
Options	Yes
Price	$83.83
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	IRMD
U.S. state	Florida
Website	https://www.iradimed.com

Metric

Value

Amount currency

USD

CIK code

0001325618

Company name

IRADIMED CORPORATION

Country

United States

Country code

CUSIP number

46266A109

Earnings date

2026-10-30

Earnings time

bmo

Employees

166

Employees change

Employees growth

3.75%

Enterprise value

$1B

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1992

In index

RUSSELL2000

Industry

Medical Devices

IPO date

2014-07-16

Is primary listing

Yes

Is SPAC

ISIN number

US46266A1097

Last 10-K release date

2026-03-06

Last earnings date

2026-07-31

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$1.1B

Market cap category

Small-Cap

Next earnings date

2026-10-30

Options

Yes

Price

$83.83

Price currency

USD

Sector

Healthcare

SIC code

3841

Stock price date

2026-10-28

Symbol

IRMD

U.S. state

Florida

Website

https://www.iradimed.com

Metric	Value
Adjusted P/E ratio	42.77x
Average P/E ratio (10Y)	62.32x
Average P/E ratio (3Y)	39.49x
Average P/E ratio (5Y)	41.29x
Earnings yield	2.14%
EV/Earnings	44.23x
EV/EBIT	37.01x
EV/EBITDA	34.94x
EV/FCF	40.6x
EV/Sales	11.81x
FCF / EV yield	2.46%
FCF yield	2.33%
Forward EV/Sales	10.15x
Forward P/E	38.77x
Forward P/S	10.74x
Graham number	17.90103
Graham upside	-78.78%
Industry forward P/E	19.81x
Industry P/E	39.5x
Lynch fair value	$44.75
Lynch upside	-46.96%
P/(FCF - SBC) ratio	48.45x
P/(OCF - SBC) ratio	44.42x
P/B ratio	10.55x
P/E ratio	46.84x
P/FCF ratio	42.95x
P/OCF ratio	39.75x
P/S ratio	12.49x
PEG ratio	3.21x
Price / tangible book value	10.97x
Price/EBITDA ratio	36.96x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Adjusted P/E ratio

42.77x

Average P/E ratio (10Y)

62.32x

Average P/E ratio (3Y)

39.49x

Average P/E ratio (5Y)

41.29x

Earnings yield

2.14%

EV/Earnings

44.23x

EV/EBIT

37.01x

EV/EBITDA

34.94x

EV/FCF

40.6x

EV/Sales

11.81x

FCF / EV yield

2.46%

FCF yield

2.33%

Forward EV/Sales

10.15x

Forward P/E

38.77x

Forward P/S

10.74x

Graham number

17.90103

Graham upside

-78.78%

Industry forward P/E

19.81x

Industry P/E

39.5x

Lynch fair value

$44.75

Lynch upside

-46.96%

P/(FCF - SBC) ratio

48.45x

P/(OCF - SBC) ratio

44.42x

P/B ratio

10.55x

P/E ratio

46.84x

P/FCF ratio

42.95x

P/OCF ratio

39.75x

P/S ratio

12.49x

PEG ratio

3.21x

Price / tangible book value

10.97x

Price/EBITDA ratio

36.96x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
EBIT margin	31.92%
EBITDA margin	33.8%
Effective tax rate	22.49%
FCF margin	29.09%
Gross margin	75.86%
Operating margin	31.92%
Pretax margin	34.45%
Profit margin	26.7%
Profit per employee	$138,886
Profitable quarters	24
Profitable years	14
Revenue per employee	$520,108
ROA	15.56%
ROA (5Y)	12.77%
ROCE	26.04%
ROE	23.52%
ROE (5Y)	20.87%
ROIC	50.37%
ROIC (5Y)	69.61%
SBC / revenue	3.3%
Tax / revenue	7.75%

Metric

Value

EBIT margin

31.92%

EBITDA margin

33.8%

Effective tax rate

22.49%

FCF margin

29.09%

Gross margin

75.86%

Operating margin

31.92%

Pretax margin

34.45%

Profit margin

26.7%

Profit per employee

$138,886

Profitable quarters

Profitable years

Revenue per employee

$520,108

ROA

15.56%

ROA (5Y)

12.77%

ROCE

26.04%

ROE

23.52%

ROE (5Y)

20.87%

ROIC

50.37%

ROIC (5Y)

69.61%

SBC / revenue

3.3%

Tax / revenue

7.75%

Metric	Value
EPS growth	11.18%
EPS growth (Q)	-9.3%
EPS growth (QoQ)	-9.3%
EPS growth 10Y	9.9%
EPS growth 3Y	15.31%
EPS growth 5Y	37.62%
EPS growth years	5
FCF growth	76.79%
FCF growth (Q)	12.6%
FCF growth (QoQ)	-27.03%
FCF growth 3Y	45.91%
FCF growth 5Y	25.84%
Gross profit growth	9.62%
Gross profit growth (Q)	-4.98%
Gross profit growth 3Y	12.77%
Gross profit growth 5Y	19.77%
Net income growth	11.61%
Net income growth (Q)	-9.63%
Net income growth (QoQ)	-10.31%
Net income growth 3Y	16.22%
Net income growth 5Y	38.23%
Net income growth years	5
OCF growth	-0.01%
OCF growth (Q)	-23.33%
OCF growth (QoQ)	-28.35%
OCF growth 10Y	12.08%
OCF growth 3Y	21.48%
OCF growth 5Y	26.6%
Operating income growth	15.74%
Operating income growth (Q)	-5.85%
Operating income growth 3Y	16.66%
Operating income growth 5Y	28.85%
Revenue growth	11.21%
Revenue growth (Q)	0.28%
Revenue growth (QoQ)	-6.88%
Revenue growth 10Y	9.31%
Revenue growth 3Y	12.97%
Revenue growth 5Y	19.6%
Revenue growth quarters	22
Revenue growth years	5

Metric

Value

EPS growth

11.18%

EPS growth (Q)

-9.3%

EPS growth (QoQ)

-9.3%

EPS growth 10Y

9.9%

EPS growth 3Y

15.31%

EPS growth 5Y

37.62%

EPS growth years

FCF growth

76.79%

FCF growth (Q)

12.6%

FCF growth (QoQ)

-27.03%

FCF growth 3Y

45.91%

FCF growth 5Y

25.84%

Gross profit growth

9.62%

Gross profit growth (Q)

-4.98%

Gross profit growth 3Y

12.77%

Gross profit growth 5Y

19.77%

Net income growth

11.61%

Net income growth (Q)

-9.63%

Net income growth (QoQ)

-10.31%

Net income growth 3Y

16.22%

Net income growth 5Y

38.23%

Net income growth years

OCF growth

-0.01%

OCF growth (Q)

-23.33%

OCF growth (QoQ)

-28.35%

OCF growth 10Y

12.08%

OCF growth 3Y

21.48%

OCF growth 5Y

26.6%

Operating income growth

15.74%

Operating income growth (Q)

-5.85%

Operating income growth 3Y

16.66%

Operating income growth 5Y

28.85%

Revenue growth

11.21%

Revenue growth (Q)

0.28%

Revenue growth (QoQ)

-6.88%

Revenue growth 10Y

9.31%

Revenue growth 3Y

12.97%

Revenue growth 5Y

19.6%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-2M
Depreciation and amortization	$1.6M
EBIT	$27.6M
EBITDA	$29.2M
EPS	$1.79
FCF per share	$1.96
Financing cash flow	$-18.5M
Free cash flow	$25.1M
Free cash flow minus SBC	$22.3M
Gross profit	$65.5M
Income taxes	$6.7M
Investing cash flow	$-2.6M
Net cash flow	$6.1M
Net income	$23.1M
Operating cash flow minus SBC	$24.3M
Operating income	$27.6M
Revenue	$86.3M
Stock-based compensation	$2.9M

Metric

Value

Capital expenditures

$-2M

Depreciation and amortization

$1.6M

EBIT

$27.6M

EBITDA

$29.2M

EPS

$1.79

FCF per share

$1.96

Financing cash flow

$-18.5M

Free cash flow

$25.1M

Free cash flow minus SBC

$22.3M

Gross profit

$65.5M

Income taxes

$6.7M

Investing cash flow

$-2.6M

Net cash flow

$6.1M

Net income

$23.1M

Operating cash flow minus SBC

$24.3M

Operating income

$27.6M

Revenue

$86.3M

Stock-based compensation

$2.9M

Metric	Value
Altman Z-Score	52.72
Book value per share	$7.96
Debt / equity	0
Long-term assets	$28.3M
Long-term liabilities	$4.1M
Net cash (debt)	$59.1M
Net cash / market cap	5.48%
Net cash growth	11.48%
Net debt / EBITDA	-2.02
Net debt / equity	-0.58
Net debt / FCF	-2.35
Piotroski F-Score	5
Property, plant and equipment	$24.2M
Shareholders' equity	$101.7M
Tangible book value	$98.3M
Tangible book value per share	$7.69
Total assets	$115M
Total cash	$59.1M
Total debt	$0
Total liabilities	$13.2M
WACC	9.27%

Metric

Value

Altman Z-Score

52.72

Book value per share

$7.96

Debt / equity

Long-term assets

$28.3M

Long-term liabilities

$4.1M

Net cash (debt)

$59.1M

Net cash / market cap

5.48%

Net cash growth

11.48%

Net debt / EBITDA

-2.02

Net debt / equity

-0.58

Net debt / FCF

-2.35

Piotroski F-Score

Property, plant and equipment

$24.2M

Shareholders' equity

$101.7M

Tangible book value

$98.3M

Tangible book value per share

$7.69

Total assets

$115M

Total cash

$59.1M

Total debt

Total liabilities

$13.2M

WACC

9.27%

Metric	Value
Asset turnover	0.78
Current assets	$86.7M
Current liabilities	$9.2M
Current ratio	9.46
Inventory turnover	1.78
Net working capital	$18.5M
Quick ratio	7.89
Working capital	$77.6M
Working capital turnover	1.18

Metric

Value

Asset turnover

0.78

Current assets

$86.7M

Current liabilities

$9.2M

Current ratio

9.46

Inventory turnover

1.78

Net working capital

$18.5M

Quick ratio

7.89

Working capital

$77.6M

Working capital turnover

1.18

Metric	Value
Buyback yield / dilution	-0.41%
Dividend growth	16.67%
Dividend growth (3Y)	-22.9%
Dividend growth years	1
Dividend payment date	2026-08-28
Dividend payment years	5
Dividend payout frequency	Quarterly
Dividend per share	$0.80
Dividend yield	0.96%
Ex-dividend date	2026-08-14
FCF payout ratio	39.2%
Last dividend	$0.20
Payout ratio	43.02%
Shareholder yield	0.54%

Metric

Value

Buyback yield / dilution

-0.41%

Dividend growth

16.67%

Dividend growth (3Y)

-22.9%

Dividend growth years

Dividend payment date

2026-08-28

Dividend payment years

Dividend payout frequency

Quarterly

Dividend per share

$0.80

Dividend yield

0.96%

Ex-dividend date

2026-08-14

FCF payout ratio

39.2%

Last dividend

$0.20

Payout ratio

43.02%

Shareholder yield

0.54%

Metric	Value
10Y price change	803.35%
10Y return CAGR	25.83%
10Y total return	894.72%
150-day SMA	$90.14
1D price change	-0.14%
1M price change	-2.57%
1M total return	-2.57%
1W price change	-5.3%
1W total return	-5.3%
1Y price change	7.5%
1Y return CAGR	8.99%
1Y total return	8.99%
20-day SMA	$86.83
200-day SMA	$92.73
3M price change	-12.12%
3M total return	-11.91%
3Y price change	102.72%
3Y return CAGR	28.51%
3Y total return	112.25%
50-day SMA	$85.88
50-day SMA vs 200-day SMA	50under200
52-week high	$107.90
52-week high date	2026-02-10
52-week low	$75.75
52-week low date	2025-10-30
5Y price change	140.05%
5Y return CAGR	21.46%
5Y total return	164.32%
6M price change	-6.2%
6M total return	-5.76%
All-time high	$107.90
All-time high date	2026-02-10
All-time low	$6.26
All-time low date	2014-09-03
Average true range (ATR)	$2.00
Average volume	106.5K
Beta (1Y)	-0.07
Beta (2Y)	0.56
Beta (5Y)	0.91
Change from 52-week high	-22.31%
Change from 52-week low	10.67%
Change from all-time high	-22.56%
Change from all-time low	1,234.82%
Change from open	-1.03%
Day's gap	0.89%
Dollar volume	$12.1M
High price	$84.70
Low price	$83.83
Monthly RSI	56.52
Open price	$84.70
Position in 52-week range	0%
Premarket change	-0.11%
Premarket close	$83.95
Premarket price	$83.86
Premarket volume	381
Previous close	$83.95
Price vs 150-day SMA	-7.3%
Price vs 20-day SMA	-3.77%
Price vs 200-day SMA	-9.89%
Price vs 50-day SMA	-2.71%
Relative volume	1.36
RSI	36.05
Sharpe ratio	0.3
Sharpe ratio (3Y)	0.88
Sharpe ratio (5Y)	0.55
Sortino ratio	0.66
Sortino ratio (3Y)	1.6
Sortino ratio (5Y)	1.01
Volume	144.3K
Weekly RSI	40.97
YTD price change	-14.1%
YTD total return	-13.54%

Metric

Value

10Y price change

803.35%

10Y return CAGR

25.83%

10Y total return

894.72%

150-day SMA

$90.14

1D price change

-0.14%

1M price change

-2.57%

1M total return

-2.57%

1W price change

-5.3%

1W total return

-5.3%

1Y price change

7.5%

1Y return CAGR

8.99%

1Y total return

8.99%

20-day SMA

$86.83

200-day SMA

$92.73

3M price change

-12.12%

3M total return

-11.91%

3Y price change

102.72%

3Y return CAGR

28.51%

3Y total return

112.25%

50-day SMA

$85.88

50-day SMA vs 200-day SMA

50under200

52-week high

$107.90

52-week high date

2026-02-10

52-week low

$75.75

52-week low date

2025-10-30

5Y price change

140.05%

5Y return CAGR

21.46%

5Y total return

164.32%

6M price change

-6.2%

6M total return

-5.76%

All-time high

$107.90

All-time high date

2026-02-10

All-time low

$6.26

All-time low date

2014-09-03

Average true range (ATR)

$2.00

Average volume

106.5K

Beta (1Y)

-0.07

Beta (2Y)

0.56

Beta (5Y)

0.91

Change from 52-week high

-22.31%

Change from 52-week low

10.67%

Change from all-time high

-22.56%

Change from all-time low

1,234.82%

Change from open

-1.03%

Day's gap

0.89%

Dollar volume

$12.1M

High price

$84.70

Low price

$83.83

Monthly RSI

56.52

Open price

$84.70

Position in 52-week range

Premarket change

-0.11%

Premarket close

$83.95

Premarket price

$83.86

Premarket volume

381

Previous close

$83.95

Price vs 150-day SMA

-7.3%

Price vs 20-day SMA

-3.77%

Price vs 200-day SMA

-9.89%

Price vs 50-day SMA

-2.71%

Relative volume

1.36

RSI

36.05

Sharpe ratio

0.3

Sharpe ratio (3Y)

0.88

Sharpe ratio (5Y)

0.55

Sortino ratio

0.66

Sortino ratio (3Y)

1.6

Sortino ratio (5Y)

1.01

Volume

144.3K

Weekly RSI

40.97

YTD price change

-14.1%

YTD total return

-13.54%

Metric	Value
Float	8.3M
Float percentage	65.15%
Shares change (QoQ)	0.02%
Shares change (YoY)	0.41%
Shares held by insiders	34.85%
Shares held by institutions	63.17%
Shares outstanding	12.8M
Short % of float	7.89%
Short % of shares	5.14%
Short ratio	4.8 days

Metric

Value

Float

8.3M

Float percentage

65.15%

Shares change (QoQ)

0.02%

Shares change (YoY)

0.41%

Shares held by insiders

34.85%

Shares held by institutions

63.17%

Shares outstanding

12.8M

Short % of float

7.89%

Short % of shares

5.14%

Short ratio

4.8 days

IRADIMED CORPORATION (IRMD)

Price

Financial snapshot

Fair-value bridge

Latest news · IRMD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All IRMD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on IRMD

Frequently asked questions